Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

AGM Statement and Proposed Board Changes

19 Jun 2014 07:00

RNS Number : 9842J
Quindell PLC
19 June 2014
 



Embargoed for release 7.00 am 19 June 2014

 

Quindell Plc

("Quindell", the "Company" or the "Group")

AGM Statement and Proposed Board Changes

 

Quindell Plc (AIM: QPP.L), the provider of sector leading expertise in software, consultancy and technology enabled outsourcing in its key markets, being Insurance, Telecommunications and their related sectors, will make the following statement at its AGM to be held at 10.00am today:

 

Current Trading

The Group is pleased to report continued positive trading, with a number of new contracts signed and existing contracts extended. The value of these contracts is expected to be in excess of £250 million per annum, subject to claims frequencies. This results in an increase in the revenues for a number of the business areas but most significantly within Legal Services, where run rate revenues are expected to increase from c.£650 million per annum to c.£900 million per annum from the start of H2 2014.

 

These contracts, with terms from one to five years in duration, are across the range of the Group's customers, including intermediaries, insurers and brokers. Significantly, this includes one of the UK's leading brokers, a subsidiary of a major global insurance company, which in the last few days has extended its relationship with the Group for a period of five years. The other major area of future growth has been the signing of multiple new telematics contracts in various geographies and the successful delivery into live implementations of a number of our telematics solutions in North America.

 

The Group's performance in cash collection and its operating cash flow progresses according to plan, with Legal Services alone collecting, on average, c.£500,000 per day during the second quarter. The Group continues to have substantial cash resources and banking facilities available to fund it during this continued period of growth. The Board is confident, in line with expectations, that the Group will return to a broadly neutral operating cash position on a quarterly basis in the third quarter of 2014 and deliver strong positive operating cash flow in the final quarter of 2014 and beyond.

 

The Group's overall performance in relation to key performance indicators (cash conversion, adjusted EBITDA and adjusted EPS) continues to provide the Board with confidence in the Group's ability to meet full year market expectations.

 

Proposed Board Changes

The Board announces its intention, following the AGM, to appoint Robert Fielding as Group Chief Executive Officer with Robert Terry remaining as Chairman of the Board. Robert Fielding is currently Chief Executive Officer of the Services Division and has overseen the growth of this division since the acquisition of the Group's first legal services business in 2012. A further announcement will be made in this regard.

 

This proposed Board change marks a continuation in the development of the Group's governance and succession planning. As previously announced at the time of the Company's full year results, it is the Company's intention to appoint additional independent Non-executive directors. This recruitment process continues, with a number of suitable candidates already identified. Further announcements will be made in due course.

 

In addition, the Company has recently made two key appointments: Stephen Joseph, formerly with Bank of America Merrill Lynch, as Head of Investor Relations; and Michael Bancroft, formerly with BTG Pactual, JP Morgan and UBS, as Head of Corporate Development. These appointments are part of the Board's continued drive to strengthen Group functions as appropriate for a business of the Group's scale.

 

 

For further information:

 

Quindell PlcRobert Terry, Chairman

 

Laurence Moorse, Group Finance Director

 

Stephen Joseph, Head of Investor Relations

Tel: 01489 864201

terryr@quindell.com

Tel: 01489 864205

moorsel@quindell.com

Tel: 01489 864200

josephs@quindell.com

 

Cenkos Securities plcJoint Broker and Nominated AdvisorStephen Keys/Bobbie Hilliam

 

Canaccord Genuity Limited

Joint Broker and Financial Advisor

Simon Bridges/Bruce Garrow

 

 

Tel: 020 7397 8900

 

 

Tel: 020 7523 8000

 

 

 

Media EnquiriesRedleaf Polhill Limited

Rebecca Sanders-Hewett

Jenny Bahr

 

Tel: 020 7382 4730

quindell@redleafpr.com

 

 

 

Notes to Editors:

About Quindell Plc

Quindell Plc is a provider of sector leading expertise in software, consultancy and technology enabled outsourcing in its key markets being insurance, telecommunications and their related sectors. Quindell enters 2014 with a run rate of gross sales approaching £600 million and approaching £200 million of EBITDA, and has announced new contract wins since the start of 2014 that amount to a further £500+ million due to start during 2014. Our award winning business transformational, software, consultancy and outsourcing solutions are recognised as delivering significant savings and additional sales to our customers every year.

For further information, please visit www.quindell.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMQKFDPKBKBFAD
Date   Source Headline
10th Feb 20207:00 amRNSPre-close update
7th Feb 20207:00 amRNSCompletion of the sale of Healthcare Services
3rd Feb 20207:00 amRNSUpdate re the sale of Healthcare services business
23rd Jan 20207:00 amRNSChange of Auditor
10th Jan 20204:40 pmRNSSecond Price Monitoring Extn
10th Jan 20204:35 pmRNSPrice Monitoring Extension
8th Jan 202011:09 amRNSHolding(s) in Company
8th Jan 202010:47 amRNSHolding(s) in Company
31st Dec 20198:00 amRNSUpdate re the sale of Healthcare services business
23rd Dec 201912:03 pmRNSHolding(s) in Company
17th Dec 20192:22 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSUpdate re the sale of Healthcare services business
22nd Oct 20194:10 pmRNSHolding(s) in Company
22nd Oct 20194:10 pmRNSHolding(s) in Company
21st Oct 20197:00 amRNSSettlement with Slater & Gordon (UK) 1 Limited
16th Oct 20194:37 pmRNSSettlement with Mr Robert Terry and others
17th Sep 20197:00 amRNSSale of Healthcare Services
4th Sep 20197:00 amRNSHalf-year Report
29th Aug 20197:03 amRNSCounterclaim against Slater & Gordon (UK) 1 Ltd
31st Jul 20197:00 amRNSAppointment of Nominated Adviser and Broker
5th Jul 20195:04 pmRNSHolding(s) in Company
1st Jul 20197:00 amRNSDirectorate Change
26th Jun 20192:14 pmRNSResult of AGM
13th Jun 20197:00 amRNSProposed counterclaim by Robert Terry and others
6th Jun 201910:23 amRNSHolding(s) in Company
3rd Jun 20197:00 amRNSAnnual Financial Report
9th May 20197:00 amRNSFinal Results
4th Apr 20191:32 pmRNSHolding(s) in Company
3rd Apr 201910:24 amRNSHolding(s) in Company
28th Mar 201910:25 amRNSHolding(s) in Company
12th Feb 20194:14 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSPre-close trading update
24th Dec 20187:00 amRNSHolding(s) in Company
3rd Dec 20182:31 pmRNSHolding(s) in Company
6th Nov 20184:57 pmRNSHolding(s) in Company
11th Oct 20183:33 pmRNSHolding(s) in Company
9th Oct 20185:20 pmRNSHolding(s) in Company
25th Sep 20185:50 pmRNSHolding(s) in Company
13th Sep 20187:00 amRNSHolding(s) in Company
30th Aug 20187:00 amRNSHalf-year Report
23rd Aug 201810:39 amRNSHolding(s) in Company
2nd Aug 20182:20 pmRNSHolding(s) in Company
29th Jun 201810:35 amRNSHolding(s) in Company
27th Jun 201811:55 amRNSAGM Results
17th May 20187:34 amRNSAnnual Financial Report
1st May 201812:27 pmRNSHolding(s) in Company
27th Apr 20187:00 amRNSFinal Results
13th Apr 20184:21 pmRNSHolding(s) in Company
16th Mar 201810:40 amRNSHolding(s) in Company
20th Feb 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.